Understanding how malaria affects immune responses
Mechanisms and consequences of extrafollicular B cell activation during malaria
This study is looking at how malaria makes it hard for our immune system to fight it off, especially by seeing how certain immune cells get too active and use up important nutrients, which stops us from building strong long-term protection; the goal is to find better ways to help our bodies defend against malaria and similar infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10892847 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the ineffective immune response to malaria, focusing on how Plasmodium parasites disrupt the body's ability to develop strong immunity. The study aims to identify how certain B cells become overly activated and create a nutrient sink that hinders the formation of lasting immune memory. By exploring these processes, the research seeks to uncover new strategies for enhancing immune responses against malaria and potentially other similar infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced malaria infections or are at high risk of malaria exposure.
Not a fit: Patients who have never been exposed to malaria or those with conditions unrelated to malaria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and vaccines for malaria, enhancing patient immunity and health outcomes.
How similar studies have performed: Other research has shown promise in understanding immune responses to infections, but this specific approach to studying B cell activation in malaria is relatively novel.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Butler, Noah Sullivan — University of Iowa
- Study coordinator: Butler, Noah Sullivan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.